Watchlist
Screener
Heat Map
Institutional
Tracker

ARPO Aerpio Pharmaceuticals

Watchlist

0.000
0.0000.00%

Close Mar 21 09:30 ET

0Market Cap0.00P/E (TTM)

0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)20.87MShares34.50052wk High0.00P/B0Float Cap31.65052wk Low--Dividend TTM1.71MShs Float65.250Historical High--Div YieldTTM0.00%Amplitude6.300Historical Low--Avg Price1Lot Size

Overview Options Financials Company News Comments

About Aerpio Pharmaceuticals Company

Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product razuprotafib is a small molecule Tie2 activator being developed for the topical ocular treatment of primary open-angle glaucoma. Other products under the pipeline are ARP-1536 and AKB-4924.

Company Profile

SymbolARPO

Company NameAerpio Pharmaceuticals

CEODr. Joseph Gardner, PhD

MarketNASDAQ

Employees12

Fiscal Year Ends12-31

Websitehttps://www.aerpio.com

Company Executives

Name
Position
Salary

Dr. Joseph Gardner, PhD
Director, President and Principal Executive Officer
--

No Data

Regina Marek
Vice President of Finance, Principal Financial and Accounting Officer
--

No Data

Steven Prelack
Chairman of the Board
--

No Data

Cheryl L. Cohen
Independent Director
--

No Data

Pravin Dugel
Independent Director
--

No Data

Anupam Dalal
Independent Director
--

No Data

Dr. Caley Castelein, M.D.
Independent Director
--

No Data

Market Insights

Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.

No. Symbol % Year-to-date